EKF Diagnostics Showcases Latest Data Management Solutions
|
By LabMedica International staff writers Posted on 05 Feb 2018 |
|
The DiaSpect Tm hemoglobin analyzer (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, UK) showcased its latest data management solutions for the DiaSpect Tm hemoglobin analyzer and Quo-Test HbA1c analyzer at MEDLAB Middle East 2018 held in Dubai, UAE from February 5-8, 2018.
EKF was among the exhibitors at the event who showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market. Among the company’s range of Point of Care (POC) hemoglobin analyzers displayed at MEDLAB Middle East were Hemo Control, DiaSpect Tm and HemataStat II. The Hemo Control POC hemoglobin analyzer is designed to provide quantitative, lab quality hemoglobin results from 25 seconds and is used in blood banks, hospitals and doctors’ offices for routine screening for anemia. The company’s DiaSpect Tm is the world’s fastest hemoglobin analyzer. DiaSpect Tm and delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The HemataStat II is a microhematocrit centrifuge that provides a quantitative hematocrit reading for up to six blood samples from one 60 second spin.
Among EKF’s range of POC diabetes analyzers on display at this year’s MEDLAB Middle East was Quo-Lab, Quo-Test, Biosen and STAT-Site M BHB. The Quo-Lab HbA1c is a semi-automated desktop analyzer for measuring glycated hemoglobin (HbA1c), while the Quo-Test HbA1c system is a fully automated hemoglobin A1c analyzer. The Biosen series of glucose analyzers include three different models and can be manufactured as single channel glucose systems or as dual channel systems that can measure lactate at the same time. The STAT-Site M BHB analyzer is used for the quantitative determination of B-Hydroxybutyrate (Beta-Hydroxybutyrate or BHB) in serum or plasma. EKF also displayed products for maternal & women’s health, including the Creamatocrit Plus POC analyzer and pregnancy tests.
At MEDLAB Middle East 2018, EKF also showcased products from its Central Laboratory division, which included the Stanbio Chemistry range of reagents, controls, calibrators and standards and its own range of benchtop lab analyzers.
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Latest MEDLAB 2018 News
- Snibe Diagnostic Displays Analyzers at MEDLAB Europe 2018
- MEDLAB Europe 2018 Presents Latest Technologies and Developments
- MedLab Middle East Continues as World's Largest Attended Laboratory Exhibition and Conference
- Fujifilm Showcases DRI-CHEM NX700 Dry Chemistry Analyzer
- Zeesan Biotech Displays DNA Automated Extraction System
- Priorclave Highlights Its Smallest Steam Sterilizer
- HORIBA Medical Launches HELO and Yumizen G Range
- Astell Scientific Showcases Latest Autoclave Range
- AXA Diagnostics Highlights SkyLAB752 System
- Block Scientific Showcases Medical Lab Equipment Devices
- BIOBASE Displays Range Of Laboratory & Medical Analyzers
- Siemens Healthineers Showcases Advanced Diagnostics Analyzers
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more
Molecular Diagnostics
view channel
Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear
Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more
First-of-Its-Kind Blood Test Detects Over 50 Cancer Types
Many cancers lack routine screening, so patients are often diagnosed only after tumors grow and spread, when options are limited. A faster, less invasive approach that broadens early detection could shift... Read more
Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more
Hematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more
Immunology
view channel
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more
Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis
Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more
Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients
Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read moreMicrobiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read more
Technology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Rapid Diagnostic Technology Utilizes Breath Samples to Detect Lower Respiratory Tract Infections
Respiratory tract infections (LRTIs) are leading causes of illness and death worldwide, particularly among vulnerable populations such as the elderly, young children, and those with compromised immune systems.... Read more
Industry
view channel
Werfen and VolitionRx Partner to Advance Diagnostic Testing for Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is a rare autoimmune disorder that causes the immune system to produce abnormal antibodies, making the blood “stickier” than normal. This condition increases the risk of... Read more
